Histacet (Cetirizine Dihydrochloride)

Histacet is indicated for the relief of symptoms associated with allergic conditions. It is commonly prescribed for:

• Seasonal allergic rhinitis (hay fever)
• Perennial allergic rhinitis
• Chronic idiopathic urticaria (hives)
• Allergic conjunctivitis causing itchy, watery eyes
• Other histamine‑mediated allergic reactions as determined by a healthcare professional

• Cetirizine dihydrochloride, the active component of Histacet, acts as a selective peripheral H1‑receptor antagonist. By binding to H1 receptors on mast cells and other tissues, it blocks the action of endogenous histamine released during allergic responses. This inhibition reduces vasodilation, increased vascular permeability, and sensory nerve stimulation, thereby diminishing typical allergy symptoms such as itching, swelling, and rhinorrhea without significant central nervous system penetration.

Histacet may cause adverse reactions, most of which are mild and transient. Serious events are rare but should be recognized.

Common

• Drowsiness or mild sedation
• Dry mouth
• Headache
• Fatigue
• Nausea
• Dizziness

Serious

• Severe allergic reaction (anaphylaxis)
• Thrombocytopenia (low platelet count)
• Hepatotoxicity (liver injury)
• Cardiac arrhythmias (rare)
• Severe skin reactions such as Stevens‑Johnson syndrome

Before using Histacet, consider the following precautions:

• Assess for known hypersensitivity to cetirizine or any component of the formulation.
• Use caution in patients with renal impairment; dosage adjustment may be required.
• Evaluate pregnancy or breastfeeding status, as safety data are limited.
• Monitor for excessive sedation if combined with other central nervous system depressants.
• Advise patients to avoid operating machinery if drowsiness occurs.
• Review concomitant use of other antihistamines to prevent additive effects.

Histacet can interact with several drug classes. Consider these interaction guidelines:

Avoid

• Concurrent use with potent CYP3A4 inhibitors (e.g., ketoconazole) that may increase cetirizine plasma levels.
• Co‑administration with other H1 antihistamines, which can amplify sedative effects.
• Use with monoamine oxidase inhibitors (MAOIs) due to potential additive antihistaminic activity.

Use with caution

• Alcohol, because it may enhance drowsiness.
• Sedative psychotropic agents (e.g., benzodiazepines, antihistamine‑containing sleep aids).
• Anticholinergic drugs, which may increase dry mouth.
• Medications that affect renal excretion (e.g., NSAIDs) in patients with compromised kidney function.